# Registry First Wave Pilot A Creatinine Source Transition S2 Execution Authorization 2026-08-24 v0.1

Status: Founder Authorized for Local Creatinine Source Transition S2 Execution / Final Version-Control Approval Pending

Founder: 蓝耀栋

Authorization date: 2026-08-24

## 1. Purpose

This document records Founder authorization to execute Creatinine Source Transition S2 locally against the exact C37 record. The resulting record remains uncommitted and requires final Founder review before any version-control action.

## 2. Repository Baseline

- Repository: /Users/lanyaodong/Documents/congtie-api
- Branch: main
- HEAD: a99b5312403d29c20383427cf746d0f26274987c
- origin/main: a99b5312403d29c20383427cf746d0f26274987c
- Initial staging: empty
- Execution date: 2026-08-24

## 3. Exact C33 Plan and Approval

| Artifact | SHA-256 |
| --- | --- |
| C33 Source-Verified Transition Plan | dd627b31e887553b85179da78f47a504ef7da5df8113b6154bbcee4ec5f70121 |
| C33 Transition Plan Founder Approval | d3d90474ef17233bd8dbe0b7cc39409db061c1b0ee30a45a0e088fe9dac2f0c8 |

C33 authorizes separate S1, S2, and S3 gates and specifies the exact lifecycle/source-check metadata boundary for S2.

## 4. Exact C36 Review Packet

Path:

agent/knowledge_seed_v0/registry_first_wave_pilot_a_creatinine_s2_source_addition_review_packet_2026_08_24.v0.1.md

SHA-256:

671654fc947a7c39bd915f44d12a049eda6697bfe098fc18b904afe39a987c44

## 5. Exact C37 Founder Approval

Path:

agent/knowledge_seed_v0/registry_first_wave_pilot_a_creatinine_s2_source_addition_founder_approval_2026_08_24.v0.1.md

SHA-256:

d34921843a9f8a1efcc65e941d3707ab838fdb930b471365bf8062d80755629b

## 6. Exact Pre-S2 Creatinine Record

Path:

agent/biomarker_measurement_registry/records/BM-000023.creatinine.json

SHA-256:

c8fd286a46334e2f9a4856503de37ff5d8f5dcdfc7128f8e5a7308ae75ae0fa6

The working-tree and HEAD copies match exactly.

## 7. C37 Prerequisite Satisfaction

The pre-S2 record satisfies all required conditions:

~~~text
SourceReference count = 7
Duplicate source keys = 0
NIDDK conversion source = present and content_verified
Profile source-reference keys = exact 4-key sequence
conversion_rule = value_mg/dL * 88.4 = value_umol/L
conversion_verified = true
RegistryConcept lifecycle = proposed
Profile status = proposed
version = v0.1
~~~

## 8. Seven-Source Verification Requirement

Before modifying the record, all seven current sources must be reopened and their identity, access, role, support scope, limitations, and withdrawal/supersession status reviewed:

1. src-loinc-creat-mass;
2. src-loinc-creat-molar;
3. src-nist-creat;
4. src-creat-method-2020;
5. src-wst4045;
6. src-ucum; and
7. src-niddk-creatinine-conversion.

No search-result summary may substitute for actual source review.

## 9. Exact Permitted Lifecycle Transition

Only these lifecycle fields may change:

~~~text
RegistryConcept.lifecycle_status:
proposed -> source_verified

creatinine.serum_or_plasma.enzymatic.profile_status:
proposed -> source_verified
~~~

No human_reviewed or active transition is authorized.

## 10. Exact Access-Date Rule

Only sources actually reopened may receive access_date 2026-08-24.

The six sources currently dated 2026-08-22 may change to 2026-08-24 after successful re-verification. The NIDDK source already dated 2026-08-24 remains unchanged. No other source field may change.

## 11. Exact Status Note

The authorized replacement status note is:

> Source verification completed for the canonical Creatinine definition and creatinine.serum_or_plasma.enzymatic Profile after exact unit-conversion authority was added. RegistryConcept and Profile are source_verified only; no assay equivalence, human review, active status, publication, runtime, retrieval, clinical claim, threshold or action authorization.

The text must not be rewritten or shortened.

## 12. Version Decision

Version remains v0.1.

This is a lifecycle/source-check metadata transition. It does not revise construct identity, Profile boundary, method, specimen, units, formula, mappings, comparability, limitations, permissions, or source content.

## 13. Strict Content Boundary

The expected deep diff contains exactly nine changed scalar leaves:

1. RegistryConcept lifecycle_status;
2. Profile profile_status;
3. six previously dated source access_date values; and
4. governance_metadata.status_note.

Authorized content additions, removals, array reordering, or governance-date changes: zero.

## 14. Final-Review Requirement

Local execution does not constitute final Founder approval of the resulting record. The revised Creatinine SHA, exact nine-leaf diff, seven-source audit, Validator results, and S2 Review Packet must be reviewed in a later final Founder gate before commit or push.

## 15. Exact Authorization Language

Founder authorizes local execution of Creatinine Source Transition S2 against the exact SHA-identified C37 record. The authorized transition changes only the Creatinine RegistryConcept and its single enzymatic Profile from `proposed` to `source_verified`, refreshes access dates only for sources actually reopened, and applies the exact C33-approved status note. The transition remains uncommitted and requires a separate final Founder review and exact-SHA version-control approval.

## 16. Explicit Non-Authorizations

This authorization does not permit:

- commit or push;
- Heart Rate S3;
- changes to Height, Body Weight, or Heart Rate;
- changes to Schema, Validator, Candidate Ledger, Migration Ledger, allocation assets, or Registry READMEs;
- source additions, deletions, rewrites, role changes, or scope changes;
- Profile additions or method, specimen, unit, formula, mapping, comparability, limitation, or permission changes;
- claims, thresholds, reference contexts, system relations, lifecycle relations, or device mappings;
- human-reviewed or active status;
- runtime, retrieval, publication, database, API, loader, index, Observation processing, Service Panel, or user-health storage;
- diagnosis, treatment, personal targets, or action.

## 17. Git Boundary

The local S2 execution must not use git add, commit, push, clean, restore, stash, reset, rebase, merge, or pull. Staging must remain empty, and unrelated working-tree content must remain untouched.

The next version-control action requires an exact-SHA Founder approval task after final review.
